1-4 of 4
Shinpei Nakazawa, MD
Close
Sort by
Journal Articles

Defining Second-Hit Genetic Abnormalities Involved in the t(12; 21) TEL-AML1 Acute Lymphoblastic Leukemia by Array-Based Comparative Genomic Hybridization.

Shinobu Tsuzuki, MD, PhD, Sivasundaram Karnan, Keizo Horibe, MD, PhD, Kimikazu Matsumoto, MD, PhD, Koji Kato, MD, PhD, Kanji Sugita, MD, PhD, Shinpei Nakazawa, MD, PhD, Masao Seto, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2845.
https://doi.org/10.1182/blood.V106.11.2845.2845
Published: 2005
Journal Articles

Induction of CD33 Expression in B-Precursor ALL by E2A-HLF Fusion Transcription Factor Derived from t(17;19).

Koshi Akahane, MD, Takeshi Inukai, MD, Toshiya Inaba, MD, Hidemitsu Kurosawa, MD, Mikiya Endo, MD, Hiroaki Goto, MD, Nobutaka Kiyokawa, MD, A. Thomas Look, MD, Kumiko Goi, MD, Kanji Sugita, MD, Shinpei Nakazawa, MD
Journal: Blood
Blood (2005) 106 (11): 851.
https://doi.org/10.1182/blood.V106.11.851.851
Published: 2005
Journal Articles

PKC412, a FLT3 Inhibitor, Effectively Induces Apoptosis of Leukemia Cells with 11q23 Translocation Particularly Having D835 Mutation.

Kazuya Takahashi, MD, Kumiko Goi, MD, Yoshiyuki Furuichi, MD, Takeshi Inukai, MD, Kanji Sugita, MD, Shinpei Nakazawa, MD
Journal: Blood
Blood (2004) 104 (11): 1886.
https://doi.org/10.1182/blood.V104.11.1886.1886
Published: 2004
Journal Articles

Acute Myeloid Leukemia (AML) - Type Chemotherapy for Newly Diagnosed Children with Myelodysplastic Syndrome (MDS): A Japanese Childhood MDS Study Group Trial MDS99.

Yoshitoshi Ohtsuka, MD, Atsushi Manabe, MD, Jun Okamura, MD, Seiji Kojima, MD, Akira Ohara, MD, Masahiro Tuchida, MD, Koichiro Ikuta, MD, Shigeyoshi Hibi, MD, Keisei Kawa, MD, Miharu Yabe, MD, Arata Watanabe, MD, Kazuhiro Ueda, MD, Shinpei Nakazawa, MD, Sumio Miyazaki, MD, Tatsutoshi Nakahata, MD
Journal: Blood
Blood (2004) 104 (11): 4726.
https://doi.org/10.1182/blood.V104.11.4726.4726
Published: 2004